These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1682379

  • 1. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane.
    Byrd LG, McDonald AH, Gold LG, Potter M.
    J Immunol; 1991 Nov 15; 147(10):3632-7. PubMed ID: 1682379
    [Abstract] [Full Text] [Related]

  • 2. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
    McDonald AH, Degrassi A.
    Cell Immunol; 1993 Jan 15; 146(1):157-70. PubMed ID: 8425224
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of plasma cell tumours with 2,6,10,14-tetramethylpentadecane (pristane) and paraffin oil (paraffinum perliquidum) in BALB/c mice simultaneously exposed to sustained antigenic stimulation with bovine serum albumin (BSA).
    Janz S, Püschel W, Raabe F, Storch H.
    Arch Geschwulstforsch; 1987 Jan 15; 57(1):25-30. PubMed ID: 3566462
    [Abstract] [Full Text] [Related]

  • 6. The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane.
    Avcu F, Ural AU, Yilmaz MI, Ozcan A, Ide T, Kurt B, Yalcin A.
    Eur J Haematol; 2005 Jun 15; 74(6):496-500. PubMed ID: 15876253
    [Abstract] [Full Text] [Related]

  • 7. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis.
    Potter M, Wax JS.
    J Immunol; 1981 Oct 15; 127(4):1591-5. PubMed ID: 7276572
    [Abstract] [Full Text] [Related]

  • 8. Disposition of the plasmacytomagenic alkane pristane (2,6,10,14-tetramethylpentadecane) in mice.
    Janz S, Shacter E.
    Cancer Biochem Biophys; 1995 Jun 15; 15(1):25-34. PubMed ID: 8536217
    [Abstract] [Full Text] [Related]

  • 9. Specific chromosome translocation in pristane-induced plasmacytomas of NZB mice.
    Oikawa T, Kuzumaki N, Yamada T.
    J Natl Cancer Inst; 1984 Feb 15; 72(2):347-53. PubMed ID: 6582321
    [Abstract] [Full Text] [Related]

  • 10. Pristane-induced autoimmunity in germ-free mice.
    Mizutani A, Shaheen VM, Yoshida H, Akaogi J, Kuroda Y, Nacionales DC, Yamasaki Y, Hirakata M, Ono N, Reeves WH, Satoh M.
    Clin Immunol; 2005 Feb 15; 114(2):110-8. PubMed ID: 15639644
    [Abstract] [Full Text] [Related]

  • 11. Differences in the induction of tumorspecific T suppressor lymphocytes among the peritoneal exudate cells in histocompatible BALB/cAnPt and BALB/cJ mouse sublines.
    Lügering N, Kölsch E.
    Immunobiology; 1991 Dec 15; 184(1):106-10. PubMed ID: 1839294
    [Abstract] [Full Text] [Related]

  • 12. Perturbation of B cell genesis in the bone marrow of pristane-treated mice. Implications for plasmacytoma induction.
    Rico-Vargas SA, Potter M, Osmond DG.
    J Immunol; 1995 Mar 01; 154(5):2082-91. PubMed ID: 7868885
    [Abstract] [Full Text] [Related]

  • 13. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
    Potter M, Morrison S, Wiener F, Zhang XK, Miller FW.
    J Natl Cancer Inst; 1994 Jul 20; 86(14):1058-65. PubMed ID: 8021954
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens.
    Potter M, Wax JS.
    J Natl Cancer Inst; 1983 Aug 20; 71(2):391-5. PubMed ID: 6576197
    [Abstract] [Full Text] [Related]

  • 18. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction.
    Müller JR, Jones GM, Potter M, Janz S.
    Cancer Res; 1996 Jan 15; 56(2):419-23. PubMed ID: 8542601
    [Abstract] [Full Text] [Related]

  • 19. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.
    Lattanzio G, Libert C, Aquilina M, Cappelletti M, Ciliberto G, Musiani P, Poli V.
    Am J Pathol; 1997 Sep 15; 151(3):689-96. PubMed ID: 9284817
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of plasmacytoma development in BALB/c mice by indomethacin.
    Potter M, Wax JS, Anderson AO, Nordan RP.
    J Exp Med; 1985 May 01; 161(5):996-1012. PubMed ID: 3989472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.